A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 Diabetes
Nauck, Michael A., Petrie, John R., Sesti, Giorgio, Mannucci, Edoardo, Courrèges, Jean-Pierre, Lindegaard, Marie L., Jensen, Christine B., Atkin, Stephen L.Language:
english
Journal:
Diabetes Care
DOI:
10.2337/dc15-0165
Date:
September, 2015
File:
PDF, 1.26 MB
english, 2015